Bernard M Branson
Overview
Explore the profile of Bernard M Branson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
3124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Branson B
Infect Dis Clin North Am
. 2019 Jun;
33(3):611-628.
PMID: 31239094
Profound changes in technology have revolutionized laboratory testing for human immunodeficiency virus (HIV) since the first laboratory enzyme immunoassays that detected only immunoglobulin G (IgG) antibodies. Instrumented fourth-generation random-access chemiluminescent...
2.
Schutzer S, Body B, Boyle J, Branson B, Dattwyler R, Fikrig E, et al.
Clin Infect Dis
. 2018 Oct;
68(6):1052-1057.
PMID: 30307486
Borrelia burgdorferi was discovered to be the cause of Lyme disease in 1983, leading to seroassays. The 1994 serodiagnostic testing guidelines predated a full understanding of key B. burgdorferi antigens...
3.
Shelus V, Taylor J, Greene E, Stanton J, Pack A, Tolley E, et al.
PLoS One
. 2018 Feb;
13(2):e0191638.
PMID: 29394259
The HPTN 065 (TLC-Plus) study tested the feasibility and effectiveness of using financial incentives (FIs) to increase linkage to care (L2C) among individuals with newly diagnosed HIV and those out...
4.
White D, Giordano T, Pasalar S, Jacobson K, Glick N, Sha B, et al.
Ann Emerg Med
. 2018 Jan;
72(1):29-40.e2.
PMID: 29310870
Study Objective: Newer combination HIV antigen-antibody tests allow detection of HIV sooner after infection than previous antibody-only immunoassays because, in addition to HIV-1 and -2 antibodies, they detect the HIV-1...
5.
Branda J, Body B, Boyle J, Branson B, Dattwyler R, Fikrig E, et al.
Clin Infect Dis
. 2017 Dec;
66(7):1133-1139.
PMID: 29228208
The cause of Lyme disease, Borrelia burgdorferi, was discovered in 1983. A 2-tiered testing protocol was established for serodiagnosis in 1994, involving an enzyme immunoassay (EIA) or indirect fluorescence antibody,...
6.
Branson B, Chavez P, Hanscom B, Greene E, McKinstry L, Buchacz K, et al.
Clin Infect Dis
. 2017 Nov;
66(10):1581-1587.
PMID: 29186421
Background: Human immunodeficiency virus (HIV) testing is critical for both HIV treatment and prevention. Expanding testing in hospital settings can identify undiagnosed HIV infections. Methods: To evaluate the feasibility of...
7.
Greene E, Pack A, Stanton J, Shelus V, Tolley E, Taylor J, et al.
PLoS One
. 2017 Feb;
12(2):e0170686.
PMID: 28182706
Background: HPTN 065 (TLC-Plus) evaluated the feasibility and effectiveness of providing quarterly $70 gift card financial incentives to HIV-infected patients on antiretroviral therapy (ART) to encourage ART adherence and viral...
8.
Schackman B, Eggman A, Leff J, Braunlin M, Felsen U, Fitzpatrick L, et al.
Public Health Rep
. 2016 Feb;
131 Suppl 1:71-81.
PMID: 26862232
Objective: The HIV Prevention Trials Network (HPTN) 065 trial sought to expand HIV screening of emergency department (ED) patients in Bronx, New York, and Washington, D.C. This study assessed the...
9.
Sullivan P, Lyons M, Czarnogorski M, Branson B
Public Health Rep
. 2016 Feb;
131 Suppl 1:1-4.
PMID: 26862224
No abstract available.
10.
Dietz P, Van Handel M, Wang H, Peters P, Zhang J, Viall A, et al.
PLoS One
. 2015 Dec;
10(12):e0144965.
PMID: 26661399
Objective: To assess HIV testing and factors associated with receipt of testing among persons with Medicaid and commercial insurance during 2012. Methods: Outpatient and laboratory claims were analyzed from two...